Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
This study is ongoing, but not recruiting participants.
Study NCT00697437   Information provided by National University Hospital, Singapore

First Received on June 11, 2008.   Last Updated on March 29, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumors
Interventions listed in this trial
Docetaxel
Ketoconazole
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Anti-Infective Agents
Antifungal Agents
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National University Hospital, Singapore


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services